| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | n/a | n/a |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | n/a | n/a |
| Pr/Book | 43.9 |
| Latest | F'cast | |
|---|---|---|
| Revenue | n/a | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-20 | n/a | (4.13) | (0.29)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-21 | n/a | (6.06) | (0.33)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | n/a | (7.03) | (0.36)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-23 | n/a | (5.23) | (0.23)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-24 | n/a | (5.46) | (0.20)¢ | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Regulatory Approval Received for KSK Transaction | 12-Mar-2026 | 07:25 | RNS |
| Regulatory Approval Received for KSK Transaction | 12-Mar-2026 | 07:25 | RNS |
| Results of General Meeting | 29-Jan-2026 | 13:30 | RNS |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 1.60p |
| Change Today | 0.060p |
| % Change | 3.90 % |
| 52 Week High | 1.80 |
| 52 Week Low | 0.73 |
| Volume | 1,065,562 |
| Shares Issued | 3,393.82m |
| Market Cap | £54.30m |
| Beta | 0.00 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| No dividends found |
| Time | Volume / Share Price |
| 15:54 | 134,786 @ 1.68p |
| 15:29 | 59,016 @ 1.68p |
| 14:20 | 19,678 @ 1.57p |
| 13:09 | 132,547 @ 1.68p |
| 11:10 | 1,514 @ 1.56p |
| CEO | Darryn McClelland |
| CFO | Leonard Aurlianus |
You are here: research